Mitochondria as a promising antiparasitic target

Current Clinical Pharmacology

Volumn 5, Issue 1, 2010, Pages 55-66

  Monzote, Lianet ^a   Gille, Lars ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Antiparasitic drugs; Helminthes; Mitochondria; Protozoa

Indexed keywords

2,5 BIS(4 AMIDINOPHENYL)FURAN; ALBENDAZOLE; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY; ARTEMETHER; ARTEMISIN; ARTESUNATE; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; BENZNIDAZOLE; CHALCONE; CHLOROQUINE; CLORSULON; CYCLOSPORIN A; DIETHYLCARBAMAZINE; DIHYDROARTEMISININ; EFLORNITHINE; IVERMECTIN; LICOCHALCONE A; MELARSOPROL; MILTEFOSINE; NIFURTIMOX; OXAMNIQUINE; PENTAMIDINE; PRAZIQUANTEL; PROGUANIL; SALICYLIC ACID; SULFADIAZINE; SURAMIN; UNINDEXED DRUG;

AFRICAN TRYPANOSOMIASIS; ASCARIS LUMBRICOIDES; BABESIOSIS; BIOENERGY; BRUGIA; BRUGIA MALAYI; BRUGIA TIMORI; CELL FUNCTION; CHAGAS DISEASE; CHEMOTHERAPY; CITRIC ACID CYCLE; COMPLEX FORMATION; DISEASE CONTROL; DRUG STRUCTURE; DRUG TARGETING; ENTAMOEBA HISTOLYTICA; ENZYME SYNTHESIS; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE SEQUENCE; GIARDIA LAMBLIA; HELMINTHIASIS; HEME SYNTHESIS; HUMAN; INTESTINE PARASITE; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA DONOVANI; LEISHMANIA MEXICANA; LEISHMANIASIS; LYMPHATIC FILARIASIS; MALARIA; METABOLISM; MITOCHONDRION; NONHUMAN; ONCHOCERCA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE; PLASMODIUM; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTOZOAL INFECTION; PYRIMIDINE SYNTHESIS; RESPIRATORY CHAIN; REVIEW; SCHISTOSOMA; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; STRUCTURE ACTIVITY RELATION; TAENIA SAGINATA; TOXOPLASMOSIS; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI; WUCHERERIA; WUCHERERIA BANCROFTI;

ANIMALS; ANTIPARASITIC AGENTS; DRUG DELIVERY SYSTEMS; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; HUMANS; MITOCHONDRIA; PARASITIC DISEASES;

EID: 77950828007     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488410790410605     Document Type: Review

References (94)

1. McKerrow JH. Designing drugs for parasitic diseases of the developing world. PLoS Med 2005; 2: 712-714
2. Pink R, Hudson A, Mouries MA, Bendig M. Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discov 2005; 4: 727-740
3. Reddy M, Gill SS, Kalkar SR, et al. Oral drug therapy for multiple neglected tropical diseases: a systematic review. JAMA 2007; 298: 1911-1924
4. Cowman AF, Crabb BS. Functional genomics: identifying drug targets for parasitic diseases. Trends Parasitol 2003; 19: 538-543
5. Watkins BM. Drugs for the control of parasitic diseases: current status and development. Trends Parasitol 2003; 19: 477-478
6. Nwaka S, Hudson A. Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov 2006; 5: 941-955
7. Werbovetz KA. Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis. Curr Med Chem 2000; 7: 835-860
8. Omura S, Crump A. The life and times of ivermectin - a success story. Nat Rev Microbiol 2004; 2: 984-989
9. Kita K, Nihei C, Tomitsuka E. Parasite mitochondria as drug target: diversity and dynamic changes during the life cycle. Curr Med Chem 2003; 10: 2535-2548
10. van Dooren GG, Stimmler LM, McFadden GI. Metabolic maps and functions of the Plasmodium mitochondrion. FEMS Microbiol Rev 2006; 30: 596-630.
11. Schneider A. Unique aspects of mitochondrial biogenesis in try-panosomatids. Int J Parasitol 2001; 31: 1403-1415
12. Moreira D, Lopez-Garcia P. Symbiosis between methanogenic archaea and delta-proteobacteria as the origin of eukaryotes: the syntrophic hypothesis. J Mol Evol 1998; 47: 517-530
13. Dyall SD, Johnson PJ. Origins of hydrogenosomes and mitochondria: evolution and organelle biogenesis. Curr Opin Microbiol 2000; 3: 404-411
14. Mather MW, Henry KW, Vaidya AB. Mitochondrial drug targets in apicomplexan parasites. Curr Drug Targets 2007; 8: 49-60.
15. Uyemura SA, Luo S, Vieira M, Moreno SN, Docampo R. Oxidative phosphorylation and rotenone-insensitive malate-and NADH-quinone oxidoreductases in Plasmodium yoelii yoelii mitochondria in situ. J Biol Chem 2004; 279: 385-393
16. Chen M, Bennedsen M, Zhai L, Kharazmi A. Purification and enzymatic activity of an NADH-fumarate reductase and other mitochondrial activities of Leishmania parasites. APMIS 2001; 109: 801-808
17. Vaidya AB. Mitochondrial and plastid functions as antimalarial drug targets. Curr Drug Targets Infect Disord 2004; 4: 11-23.
18. Mi-Ichi F, Takeo S, Takashima E, et al. Unique properties of respiratory chain in Plasmodium falciparum mitochondria. Adv Exp Med Biol 2003; 531: 117-133
19. Fry M, Beesley JE. Mitochondria of mammalian Plasmodium spp. Parasitology 1991; 102 Pt 1: 17-26.
20. Krungkrai J, Krungkrai SR, Bhumiratana A. Plasmodium berghei: partial purification and characterization of the mitochondrial cyto- chrome c oxidase. Exp Parasitol 1993; 77: 136-146
21. Horvath A, Berry EA, Huang LS, Maslov DA. Leishmania tarento-lae: a parallel isolation of cytochrome bc(1) and cytochrome c oxidase. Exp Parasitol 2000; 96: 160-167
22. Shaw JM, Simpson L. Characterization of a protein fraction containing cytochromes b and c1 from mitochondria of Leishmania tarentolae. Exp Parasitol 1989; 68: 443-449
23. Mukherjee A, Padmanabhan PK, Sahani MH, Barrett MP, Madhubala R. Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani. Mol Biochem Parasitol 2006; 145: 1-10.
24. Krungkrai J. The multiple roles of the mitochondrion of the malarial parasite. Parasitology 2004; 129: 511-524
25. Cauchetier E, Loiseau PM, Lehman J, et al. Characterisation of atovaquone resistance in Leishmania infantum promastigotes. Int J Parasitol 2002; 32: 1043-1051
26. Schnaufer A, Sbicego S, Blum B. Antimycin A resistance in a mutant Leishmania tarentolae strain is correlated to a point mutation in the mitochondrial apocytochrome b gene. Curr Genet 2000;37: 234-241
27. Debrabant A, Lee N, Bertholet S, Duncan R, Nakhasi HL. Programmed cell death in trypanosomatids and other unicellular organisms. Int J Parasitol 2003; 33: 257-267
28. Gille L, Rosenau T, Kozlov AV, Gregor W. Ubiquinone and tocopherol: dissimilar siblings. Biochem Pharmacol 2008; 76: 289-302.
29. Hines V, Keys LD, III, Johnston M. Purification and properties of the bovine liver mitochondrial dihydroorotate dehydrogenase. J Biol Chem 1986; 261: 11386-11392
30. Loffler M, Jockel J, Schuster G, Becker C. Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides. Mol Cell Biochem 1997; 174: 125-129
31. Baldwin J, Farajallah AM, Malmquist NA, Rathod PK, Phillips MA. Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity. J Biol Chem 2002; 277: 41827-41834
32. Painter HJ, Morrisey JM, Mather MW, Vaidya AB. Specific role of mitochondrial electron transport in blood-stage Plasmodium falci-parum. Nature 2007; 446: 88-91.
33. Vanlerberghe GC, McIntosh L. Alternative oxidase: from gene to function. Annu Rev Plant Physiol Plant Mol Biol 1997; 48: 703-734
34. Suzuki T, Hashimoto T, Yabu Y, et al. Direct evidence for cyanide-insensitive quinol oxidase (alternative oxidase) in apicom- plexan parasite Cryptosporidium parvum: phylogenetic and therapeutic implications. Biochem Biophys Res Commun 2004; 313: 1044-1052
35. Riordan CE, Langreth SG, Sanchez LB, Kayser O, Keithly JS. Preliminary evidence for a mitochondrion in Cryptosporidium par-vum: phylogenetic and therapeutic implications. J Eukaryot Microbiol 1999; 46: 52S-5S.
36. Clarkson AB, Jr., Bienen EJ, Pollakis G, Grady RW. Respiration of bloodstream forms of the parasite Trypanosoma brucei brucei is dependent on a plant-like alternative oxidase. J Biol Chem 1989; 264: 17770-17776
37. 2;-fixing activity in Plasmodium falciparum grown in vitro in human erythrocytes. J Protozool 1984; 31: 167-169
38. 14;C)glucose into the soluble metabolic intermediates of malaria parasites. Am J Trop Med Hyg 1964; 13: 515-519
39. Ellis JE, Setchell KD, Kaneshiro ES. Detection of ubiquinone in parasitic and free-living protozoa, including species devoid of mitochondria. Mol Biochem Parasitol 1994; 65: 213-224
40. van Hellemond JJ, Van Remoortere A, Tielens AG. Schistosoma mansoni sporocysts contain rhodoquinone and produce succinate by fumarate reduction. Parasitology 1997; 115 ( Pt 2): 177-182
41. Yamashita T, Ino T, Miyoshi H, et al. Rhodoquinone reaction site of mitochondrial complex I, in parasitic helminth, Ascaris suum. Biochim Biophys Acta 2004; 1608: 97-103.
42. Krungkrai J. Purification, characterization and localization of mitochondrial dihydroorotate dehydrogenase in Plasmodium falciparum, human malaria parasite. Biochim Biophys Acta 1995; 1243: 351-360
43. Rock CO, Cronan JE. Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis. Biochim Biophys Acta 1996; 1302: 1-16.
44. Ralph SA. Strange organelles-Plasmodium mitochondria lack a pyruvate dehydrogenase complex. Mol Microbiol 2005; 55: 1-4.
45. Stephens JL, Lee SH, Paul KS, Englund PT. Mitochondrial fatty acid synthesis in Trypanosoma brucei. J Biol Chem 2007; 282: 4427-4436
46. Sato S, Clough B, Coates L, Wilson RJ. Enzymes for heme biosynthesis are found in both the mitochondrion and plastid of the malaria parasite Plasmodium falciparum. Protist 2004; 155: 117-125
47. Nagaraj VA, Arumugam R, Gopalakrishnan B, et al. Unique properties of Plasmodium falciparum porphobilinogen deaminase. J Biol Chem 2008; 283: 437-444
48. Kolesnikova OA, Entelis NS, Mireau H, et al. Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm. Science 2000; 289: 1931-1933
49. Shapiro TA. Mitochondrial topoisomerase II activity is essential for kinetoplast DNA minicircle segregation. Mol Cell Biol 1994; 14: 3660-3667
50. Gao Y, Sun Z, Sun X, Sun Y, Shi W. Toxic effects of albendazole on adenosine triphosphatase activity and ultrastructure in Eisenia fetida. Ecotoxicol Environ Saf 2007; 67: 378-384
51. Delorenzi JC, Attias M, Gattass CR, et al. Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimicrob Agents Chemother 2001; 45: 1349-1354
52. Dantas-Leite L, Urbina JA, de Souza W, Vommaro RC. Selective anti-Toxoplasma gondii activities of azasterols. Int J Antimicrob Agents 2004; 23: 620-626
53. Muelas-Serrano S, Perez-Serrano J, Gomez-Barrio A, Aran VJ, Rodriguez-Caabeiro F. Ultrastructural alterations induced by nifur-timox and another nitro derivative on epimastigotes of Trypano-soma cruzi. Parasitol Res 2002; 88: 97-101.
54. Magan R, Marin C, Rosales MJ, Salas JM, Sanchez-Moreno M. Therapeutic potential of new Pt(II) and Ru(III) triazole-pyrimidine complexes against Leishmania donovani. Pharmacology 2005; 73: 41-48
55. Ott R, Chibale K, Anderson S, et al. Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration. Acta Trop 2006; 100: 172-184
56. Chen M, Zhai L, Christensen SB, Theander TG, Kharazmi A. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrob Agents Chemother 2001; 45: 2023-2029
57. Krudsood S, Patel SN, Tangpukdee N, et al. Efficacy of atova-quone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg 2007; 76: 655-658
58. Raju M, Salazar JC, Leopold H, Krause PJ. Atovaquone and azithromycin treatment for babesiosis in an infant. Pediatr Infect Dis J 2007; 26: 181-183
59. Alves CF, Vitor RW. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil. Parasite 2005; 12: 171-177
60. Biagini GA, Fisher N, Berry N, et al. Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex. Mol Pharmacol 2008; 73: 1347-1355
61. Winter RW, Kelly JX, Smilkstein MJ, et al. Antimalarial quinolones: synthesis, potency, and mechanistic studies. Exp Parasitol 2008; 118: 487-497
62. Christen P, Veuthey JL. New trends in extraction, identification and quantification of artemisinin and its derivatives. Curr Med Chem 2001; 8: 1827-1839
63. Rosenthal PJ. Antimalarial drug discovery: old and new approaches. J Exp Biol 2003; 206: 3735-3744
64. Ittarat W, Sreepian A, Srisarin A, Pathepchotivong K. Effect of dihydroartemisinin on the antioxidant capacity of P. falciparum-infected erythrocytes. Southeast Asian J Trop Med Public Health 2003; 34: 744-750
65. Lin Q, Katakura K, Suzuki M. Inhibition of mitochondrial and plastid activity of Plasmodium falciparum by minocycline. FEBS Lett 2002; 515: 71-74
66. Xiao SU, Utzinger J, Shen BG, Tanner M, Chollet J. Ultrastructural alterations of adult Schistosoma haematobium harbored in mice following artemether administration. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2006; 24: 321-328
67. Chen PQ, Yuan J, Du QY, et al. Effects of dihydroartemisinin on fine structure of erythrocytic stages of Plasmodium berghei ANKA strain. Acta Pharmacol Sin 2000; 21: 234-238
68. Lyddiard JR, Whitfield PJ, Bartlett A. Antischistosomal bioactivity of isoflavonoids from Millettia thonningii (Leguminosae). J Parasi-tol 2002; 88: 163-170
69. Omura S, Miyadera H, Ui H, et al. An anthelmintic compound, nafuredin, shows selective inhibition of complex I in helminth mitochondria. Proc Natl Acad Sci USA 2001; 98: 60-62
70. Luque-Ortega JR, Martinez S, Saugar JM, et al. Fungus-elicited metabolites from plants as an enriched source for new leishmanicidal agents: antifungal phenyl-phenalenone phytoalexins from the banana plant (Musa acuminata) target mitochondria of Leishmania donovani promastigotes. Antimicrob Agents Chemother 2004; 48: 1534-1540
71. Yabu Y, Yoshida A, Suzuki T, et al. The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice. Parasitol Int 2003; 52: 155-164
72. Verma NK, Singh G, Dey CS. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction. Exp Parasitol 2007; 116: 1-13.
73. Deolindo P, Teixeira-Ferreira AS, Melo EJ, et al. Programmed cell death in Trypanosoma cruzi induced by Bothrops jararaca venom. Mem Inst Oswaldo Cruz 2005; 100: 33-38
74. Silva CF, Meuser MB, De Souza EM, et al. Cellular effects of reversed amidines on Trypanosoma cruzi. Antimicrob Agents Chemother 2007; 51: 3803-3809
75. Lanteri CA, Trumpower BL, Tidwell RR, Meshnick SR. DB75, a novel trypanocidal agent, disrupts mitochondrial function in Saccharo- myces cerevisiae. Antimicrob Agents Chemother 2004; 48: 3968-3974
76. Lanteri CA, Tidwell RR, Meshnick SR. The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei. Antimicrob Agents Chemother 2008; 52: 875-882
77. Delfin DA, Bhattacharjee AK, Yakovich AJ, Werbovetz KA. Activity of and initial mechanistic studies on a novel antileishmanial agent identified through in silico pharmacophore development and database searching. J Med Chem 2006; 49: 4196-4207
78. Tavares J, Ouaissi A, Lin PK, Tomas A, Cordeiro-da-Silva A. Differential effects of polyamine derivative compounds against Leishmania infantum promastigotes and axenic amastigotes. Int J Parasitol 2005; 35: 637-646
79. Bernacchi AS, Franke DC, Castro JA. Trypanocidal action of 2, 4-dichloro-6-phenylphenoxyethyl diethylamine hydrobromide (Lilly 18947) on Trypanosoma cruzi. Acta Pharmacol Sin 2002; 23: 399-404.
80. Tempone AG, da Silva AC, Brandt CA. et al. Synthesis and an-tileishmanial activities of novel 3-substituted quinolines. Antimi- crob Agents Chemother 2005; 49: 1076-1080
81. Nduati EW, Kamau EM. Multiple synergistic interactions between atovaquone and antifolates against Plasmodium falciparum in vitro: a rational basis for combination therapy. Acta Trop 2006; 97: 357-363
82. Meaney M, Fairweather I, Brennan GP, Forbes AB. Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon. Parasitol Res 2004; 92: 232-241
83. McLauchlan PE, Roberts HC, Chappell LH. Mode of action of cyclosporin A against Hymenolepis microstoma (Cestoda): relationship between cyclophilin binding and drug-induced damage. Parasitology 2000; 121 Pt 6: 661-670
84. Colebrook AL, Jenkins DJ, Jones MK, Tatarczuch L, Lightowlers MW. Effect of cyclosporin A on the survival and ultrastructure of Echinococcus granulosus protoscoleces in vitro. Parasitology 2004; 129: 497-504.
85. Das B, Tandon V, Saha N. Effects of phytochemicals of Flemingia vestita (Fabaceae) on glucose 6-phosphate dehydrogenase and enzymes of gluconeogenesis in a cestode (Raillietina echinobothrida). Comp Biochem Physiol C Toxicol Pharmacol 2004; 139: 141-146
86. Luque-Ortega JR, van't Hof W, Veerman EC, Saugar JM, Rivas L. Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania. FASEB J 2008; 22: 1817-1828
87. Lyddiard JR, Whitfield PJ, Bartlett A. Antischistosomal bioactivity of isoflavonoids from Millettia thonningii (Leguminosae). J Parasitol 2002;163-170
88. Santa-Rita RM, Lira R, Barbosa HS, Urbina JA, de Castro SL. Anti-proliferative synergy of lysophospholipid analogues and keto-conazole against Trypanosoma cruzi (Kinetoplastida: Trypanoso-matidae): cellular and ultrastructural analysis. J Antimicrob Chemother 2005; 55: 780-784
89. Mathis A, Wild P, Deplazes P, Boettger EC. The mitochondrial ribosome of the protozoan Acanthamoeba castellanii is the target for macrolide antibiotics. Mol Biochem Parasitol 2004; 135: 225-229
90. Menna-Barreto RF, Henriques-Pons A, Pinto AV, et al. Effect of a beta-lapachone-derived naphthoimidazole on Trypanosoma cruzi: identification of target organelles. J Antimicrob Chemother 2005; 56: 1034-1041
91. Menna-Barreto RF, Correa JR, Pinto AV, Soares MJ, de Castro SL. Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from beta-lapachone. Parasitol Res 2007; 101: 895-905.
92. McKinstry B, Brennan GP, Halferty L, Forbes AB, Fairweather I. Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax). Parasitol Res 2007; 101: 929-941
93. Rodrigues JC, Bernardes CF, Visbal G, et al. Sterol methenyl transferase inhibitors alter the ultrastructure and function of the Leishmania amazonensis mitochondrion leading to potent growth inhibition. Protist 2007; 158: 447-456
94. De Carvalho EA, Andrade PP, Silva NH, Pereira EC, Figueiredo RC. Effect of usnic acid from the lichen Cladonia substellata on Trypanosoma cruzi in vitro: an ultrastructural study. Micron 2005; 36: 155-161